daup h i n cm s .org Features START YOUR ENGINES! CARS ARE DRIVING THE NEXT GENERATION OF CANCER THERAPIES S ince 1935, cancer has remained the second leading cause of mortality with a steadily increasing number of new cases yearly.1,2 Prices for cancer medications, such as Lomustine, which has been indicated for Hodgkin lymphoma and brain tumors since 1976, have consistently increased by as much as 1,400%. 3 Although our molecular understanding behind the pathogenesis of this disease has greatly increased, patients plagued by the latter stages of cancer still possess limited By YAN LEYFMAN Medical Student, Penn State College of Medicine 6 Spring 2018 Central PA Medicinehttp://www.dauphincms.org